ODAIA Introduces AI Marketing Orchestration for Pharma

ODAIA has announced its entry into the omnichannel marketing orchestration space with a new AI-powered solution designed for pharmaceutical brand teams. In a press release, the company revealed that this offering will enable personalized engagement with healthcare professionals (HCPs) by using predictive insights on prescribing behavior rather than traditional personas.

The new capabilities will allow pharma companies to coordinate marketing and sales efforts more effectively by delivering personalized campaign sequences tailored to each HCP. This includes recommendations on the best channel, message, content type, and timing, ensuring that interactions occur at the optimal moment in the decision-making process.

ODAIA's flagship AI platform, MAPTUAL, processes customer data rapidly, providing commercial teams with predictive insights and optimizing go-to-market strategies. The platform's users have reported an average increase of 7-14% in new patients starting therapy compared to non-users.

The company is launching an early access program for interested pharma companies to test and provide feedback on these new features. This initiative underscores ODAIA's commitment to enhancing the omnichannel market, which is estimated to be worth up to $8 billion globally.